Rare diseases
Investigational molecules
Locations
101 Glen Lennox Drive Suite 300 Suite 3005, 27517-4086, United States
Areteia Therapeutics Inc. focuses on eosinophilic asthma, with clinical research centered on symptom control and reduction of disease burden in adolescents and adults.
The sponsor’s trial portfolio includes studies across multiple countries and research sites, reflecting a concentrated interest in respiratory disease management.
Areteia Therapeutics Inc. runs clinical trials in conditions such as Asthma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
CzechiaStudy on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma
PolandLong-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials
BulgariaStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
BulgariaStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
